Dissemination

July 12-15, 2015:
TES Pharma together with UMC Utrecht present a poster at the Spanish-Italian Medicinal Chemistry Congress in Barcelona, Spain. Dissecting the Role of the S2 Non-Canonical Binding Pocket on Farnesoid X Receptor Activity. A. Gioiello, G. Ciaccioli, A. Carotti, D. Passeri, S. Mostarda, F. De Franco, L. Rossini, C. Beato, G. Costantino, S.W.C. Van Mil, R. Pellicciari.

October 7-8, 2014:
Consortium members of TES Pharma and UMC Utrecht present a joined poster at the XXIII International Bile Acid Meeting: 'Bile acids as signal integrators and metabolic integrators', Freiburg, Germany. Poster by: Ingrid Bijsmans1, Chiara Guercini2, Daniela Passeri2, Daphne Lelieveld3, Wienand Omta3, David Egan3, Roberto Pellicciari2, and Saskia van Mil1.
1: Center for Molecular Medicine and 3: Cell Screening Center, Department of Cell Biology; UMC Utrecht, Utrecht, the Netherlands; 2: TES Pharma s.r.l., Corciano, Perugia, Italy. High-throughput compound library screen to identify selective FXR agonists for inflammatory bowel disease.

September 29, 2014:
Saskia van Mil presents work of the FXR-IBD consortium at symposium organized by the Center for Molecular Medicine: 'Bile acids have the gall to act as hormones'.CMM symposium

September 26, 2014:
FXR-IBD symposium: 'Microbiota in inflammatory Bowel Disease: innovation in diagnostic and therapeutical tools'
Enterome, Paris, France. For program, see FXR-IBD symposium.

March 22 2014:
Dutch Experimental Gastroenterology and Hepatology Meeting (DEGH), March 20/21 2014, Veldhoven, The Netherlands
Ingrid TGW Bijsmans, Daphne Lelieveld, David A Egan, and Saskia WC van Mil
High-throughput compound library screen to identify selective FXR agonists for inflammatory bowel disease

January 2014:
Press release Kick off meeting FXR-IBD (link to pdf)

September 2013: 
Interview Saskia van Mil in International Innovation on her research topic selective FXR ligands (link to pdf).